Sign In
Buy RETA
$172.36
+0 (+0%)
At Close: Dec 22, 2023
Dow Dips 375 Points; S&P 500 Down Over 2%
06:33pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 375 points on Friday.
The Dow traded down 1.25% to 29,662.76 while the NASDAQ fell 2.68% to 10,363.83. The S&P 50
Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session
04:24pm, Friday, 14'th Oct 2022 Benzinga
Gainers
Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.
Gravitas Education Holdings, Inc. (NASDAQ: GEHI) shares jumped 66% to $24.90.
Avenue Therapeutics, Inc. (NASDAQ
Nasdaq Tumbles Over 200 Points; Crude Oil Falls Sharply
04:05pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.
The Dow traded down 0.74% to 29,817.07 while the NASDAQ fell 2.09% to 10,426.14. The
Wells Fargo, JPMorgan, Citigroup And Some Other Big Stocks Moving Higher On Friday
03:25pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower, with the Dow Jones gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.
Gravitas Education Holdings, Inc. (NASDAQ: GEHI) sh
US Stocks Open Lower; Dow Drops Over 100 Points
02:59pm, Friday, 14'th Oct 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Friday.
Following the market opening Friday, the Dow traded down 0.37% to 29,927.92 while the NASDAQ fell 1.4
Why Is Reata Pharmaceuticals (RETA) Stock Up 15% Today?
02:16pm, Friday, 14'th Oct 2022
On a sharply down day at the tail end of the week, Reata Pharmaceuticals (NASDAQ: RETA ) provided a dramatic counterpoint. While the benchmark S&P 500 index slipped near 2% down, RETA stock gained ove
Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks
12:58pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.
Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks
10:32am, Tuesday, 04'th Oct 2022
Reata Pharmaceuticals (RETA) is yet to generate product revenues due to the lack of marketed drugs in its portfolio. However, two of its pipeline candidates are close to potential FDA approval.
Why Is Kodiak Sciences Inc. (KOD) Down 23.8% Since Last Earnings Report?
03:30pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
09:26am, Thursday, 08'th Sep 2022 Benzinga
Gainers
IMARA Inc. (NASDAQ: IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontr
Reata Pharmaceuticals, Inc. (RETA) Up 4.7% Since Last Earnings Report: Can It Continue?
03:30pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Reata Pharmaceuticals, Inc. (RETA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Baird Maintains Neutral Rating for Reata Pharmaceuticals: Here's What You Need To Know
04:23pm, Tuesday, 09'th Aug 2022 Benzinga
Baird has decided to maintain its Neutral rating of Reata Pharmaceuticals (NASDAQ:RETA) and lower its price target from $37.00 to $27.00.
Shares of Reata Pharmaceuticals are trading down 8.1% over the
Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down
03:56pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down
01:32pm, Tuesday, 09'th Aug 2022
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
07:24am, Tuesday, 09'th Aug 2022 Benzinga
Gainers
Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
TOP Financial Group Limited (NASDAQ: TOP) jumped 102.7% to settle at $20.57 after gain
